The concentrations of MBL and MASP-2 in serum were found to be higher in patients suffering from papillary thyroid carcinoma compared with healthy controls and patients diagnosed with thyroid adenoma [84]. This evidence concerns the gene MBL2 and Thyroid adenoma.